Start Forschung Abteilungen / AGs / Institute Psychiatrie und Psychotherapie Arbeitsgruppen AG Schizophrenieforschung Publikationen

Publikationen: Schizophrenieforschung

Bechdolf A, Wagner M, Ruhrmann S, Harrigan S, Putzfeld V, Pukrop R, Brockhaus-Dumke A, Berning J, Janssen B, Decker P, Bottlender R, Maurer K, Möller HJ, Gaebel W, Häfner H, Maier W, Klosterkötter J. Preventing progression to first-episode psychosis in early initial prodromal states. Br J Psychiatry. 2012 200(Jan):22-9. Epub 2011 Nov 10.
Gaebel W, Buchkremer G, Häfner H, Klosterkötter J, Maier W, Wölwer W. [12 Years of Competence Network Schizophrenia: Results and Perspectives]. Fortschr Neurol Psychiatr. 2014 82(4):191-202.
Gaebel W, Riesbeck M, Wölwer W, Klimke A, Eickhoff M, von Wilmsdorff M, Jockers-Scherübl MC, Kühn KU, Lemke M, Bechdolf A, Bender S, Degner D, Schlösser R, Schmidt LG, Schmitt A, Jäger M, Buchkremer G, Falkai P, Klingberg S, Köpcke W, Maier W, Häfner H, Ohmann C, Salize HJ, Schneider F, Möller HJ, German Study Group on First-Episode Schizophrenia G. Maintenance treatment with risperidone or low-dose haloperidol in first-episode schizophrenia: 1-year results of a randomized controlled trial within the German Research Network on Schizophrenia. J Clin Psychiatry. 2007 68(11):1763-74.
Häfner H. Ist die Diagnose Schizophrenie noch sinnvoll?. Psychiatr Prax. 2007 34(4):175-80.
Häfner H. [Karl Jaspers : 100 years of "Allgemeine Psychopathologie" (General Psychopathology).]. Nervenarzt. 2013 84(11):1281-2. Epub 2013 Oct 13.
Häfner H. [Karl Jaspers. 100 years "Allgemeine Psychopathologie". Reply]. Nervenarzt. 2015 86(1):96-7.
Häfner H. Gender differences in schizophrenia. Psychoneuroendocrinology. 2003 28 Suppl 2:17-54.
Häfner H. From the catastrophe to a humane mental-health care and successful research in German psychiatry (1951-2012) -- as I remember it. Acta Psychiatr Scand. 2013 127(6):415-32.
Häfner H. Frühe Behandlung erspart viel Leid. MMW Fortschr Med. 2007 149(13):26-7.
Häfner H. Descriptive psychopathology, phenomenology, and the legacy of Karl Jaspers. Dialogues Clin Neurosci. 2015 17(1):19-29.
Häfner H. What is schizophrenia? 25 years of research into schizophrenia - the Age Beginning Course Study. World J Psychiatry. 2015 5(2):167-9.
Häfner H. The concept of schizophrenia : from unity to diversity. Adv in psychiatry. 2014
Häfner H. Das Grauen hat ein Ende. Die Psychiatriereform in Deutschland West und Ost. Die Psychiatrie. 2015 12(4):235-240.
Häfner H, Baeyer W. V., Kisker K. P.. Dringliche Reformen in der psychiatrischen Krankenversorgung der Bundesrepublik. Helfen und heilen. 1965 (4):1-8.
Häfner H, Bebbington P, Morgan C. Passing the baton: a new chief editor for social psychiatry and psychiatric epidemiology. Soc Psychiatry Psychiatr Epidemiol. 2013 48(1):1-3. Epub 2012 Dec 21.
Häfner H, Maurer K. Early detection of schizophrenia: current evidence and future perspectives. World Psychiatry. 2006 5(3):130-8.
Häfner H, Maurer K, Löffler W, an der Heiden W, Munk-Jørgensen P, Hambrecht M, Riecher-Rössler A. The ABC Schizophrenia Study: a preliminary overview of the results. Soc Psychiatry Psychiatr Epidemiol. 1998 33(8):380-6.
Häfner H, Maurer K, an der Heiden W. [Schizophrenia - a disorder in its own right? : Results from 25 years of the ABC study.]. Nervenarzt. 2013 84:1093-1103. Epub 2013 May 23.
Häfner H, Maurer K, an der Heiden W. ABC Schizophrenia study: an overview of results since 1996. Soc Psychiatry Psychiatr Epidemiol. 2013 48(7):1021-31.
Häfner H, Propping P, an der Heiden W, Ropeter D. Reduced fertility in schizophrenia : a consequence of the disorder, or premorbid personality or other factors?. JJ Epidemiol Prevent. 2015 1(2):015.
Häfner H, Sommer F. [Was the expert medical opinion rendered by B. von Gudden regarding King Ludwig II of Bavaria correct?]. Nervenarzt. 2011 82(5):611-6.
Häfner H, Sommer F. The Bavarian royal drama of 1886 and the misuse of psychiatry: new results. Hist Psychiatr. 2013 24(3):274-91.
Häfner H, an der Heiden W, Maurer K. Evidence for separate diseases?: Stages of one disease or different combinations of symptom dimensions?. Eur Arch Psychiatry Clin Neurosci. 2008 258 Suppl 2:85-96.
Lennertz L, Quednow BB, Schuhmacher A, Petrovsky N, Frommann I, Schulze-Rauschenbach S, Landsberg MW, Steinbrecher A, Höfels S, Pukrop R, Klosterkötter J, Franke PE, Wölwer W, Gaebel W, Häfner H, Maier W, Wagner M, Mössner R. The functional coding variant Asn107Ile of the neuropeptide S receptor gene (NPSR1) is associated with schizophrenia and modulates verbal memory and the acoustic startle response. Int J Neuropsychopharmacol. 2012 15(9):1205-15. Epub 2011 Nov 14.
Lennertz L, Rujescu D, Wagner M, Frommann I, Schulze-Rauschenbach S, Schuhmacher A, Landsberg MW, Franke P, Möller HJ, Wölwer W, Gaebel W, Häfner H, Maier W, Mössner R. Novel Schizophrenia Risk Gene TCF4 Influences Verbal Learning and Memory Functioning in Schizophrenia Patients. Neuropsychobiology. 2011 63(3):131-136.
Lennertz L, Wagner M, Frommann I, Schulze-Rauschenbach S, Schuhmacher A, Kühn KU, Pukrop R, Klosterkötter J, Wölwer W, Gaebel W, Rietschel M, Häfner H, Maier W, Mössner R. A coding variant of the novel serotonin receptor subunit 5-HT3E influences sustained attention in schizophrenia patients. Eur Neuropsychopharmacol. 2010 20(6):414-20. Epub 2010 Mar 30.
Lennertz L, Wagner M, Wölwer W, Schuhmacher A, Frommann I, Berning J, Schulze-Rauschenbach S, Landsberg MW, Steinbrecher A, Alexander M, Franke PE, Pukrop R, Ruhrmann S, Bechdolf A, Gaebel W, Klosterkötter J, Häfner H, Maier W, Mössner R. A promoter variant of SHANK1 affects auditory working memory in schizophrenia patients and in subjects clinically at risk for psychosis. Eur Arch Psychiatry Clin Neurosci. 2012 262(2):117-24. Epub 2011 Sep 7..
Maurer K, Häfner H. Erste Signale einer Psychose richtig deuten. MMW Fortschr Med. 2007 149(13):36-8.
Maurer K, Häfner H. Rasch scaling of a screening instrument. Sage open. 2014 4(3)
Maurer K, Trendler G, Schmidt M, an der Heiden W, Könnecke R, Häfner H. [Schizophrenia and depression]. Nervenarzt. 2006 77(7):809-22.
Munk-Jorgensen P, Häfner H. Biography Heinz Häfner. Acta Psychiatr Scand. 2013 127(6):496.
Mössner R, Schuhmacher A, Schulze-Rauschenbach S, Kühn KU, Rujescu D, Rietschel M, Zobel A, Franke P, Wölwer W, Gaebel W, Häfner H, Wagner M, Maier W. Further evidence for a functional role of the glutamate receptor gene GRM3 in schizophrenia. Eur Neuropsychopharmacol. 2008 18(10):768-72.
Raballo A, Meneghelli A, Cocchi A, Sisti D, Rocchi MB, Alpi A, Cascio MT, Preti A, Maurer K, Häfner H. Shades of vulnerability: latent structures of clinical caseness in prodromal and early phases of schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2014 264(2):155-69. Epub 2013 Jul 9.
Rabinowitz J, Levine SZ, Haim R, Häfner H. The course of schizophrenia: progressive deterioration, amelioration or both?. Schizophr Res. 2007 91(1-3):254-8.
Rabinowitz J, Levine SZ, Häfner H. A population based elaboration of the role of age of onset on the course of schizophrenia. Schizophr Res. 2006 88(1-3):96-101.
Ruhrmann S, Bechdolf A, Kühn KU, Wagner M, Schultze-Lutter F, Janssen B, Maurer K, Häfner H, Gaebel W, Möller HJ, Maier W, Klosterkötter J, LIPS study group . Acute effects of treatment for prodromal symptoms for people putatively in a late initial prodromal state of psychosis. Br J Psychiatry Suppl. 2007 51:s88-95.
Schennach-Wolff R, Seemüller FH, Mayr A, Maier W, Klingberg S, Heuser I, Klosterkötter J, Gastpar M, Häfner H, Sauer H, Schneider F, Gaebel W, Jäger M, Möller HJ, Riedel M. An early improvement threshold to predict response and remission in first-episode schizophrenia. Br J Psychiatry. 2010 196:460-6.
Schindowski K, Peters J, Gorriz C, Schramm U, Weinandi T, Leutner S, Maurer K, Frölich L, Müller WE, Eckert A. Apoptosis of CD4+ T and natural killer cells in Alzheimer's disease. Pharmacopsychiatry. 2006 39(6):220-8.
Schuhmacher A, Becker T, Rujescu D, Quednow BB, Lennertz L, Wagner M, Benninghoff J, Rietschel M, Häfner H, Franke P, Wölwer W, Gaebel W, Maier W, Mössner R. Investigation of tryptophan hydroxylase 2 (TPH2) in schizophrenia and in the response to antipsychotics. J Psychiatr Res. 2012 46(8):1073-80. Epub 2012 May 30..
Wessels H, Wagner M, Frommann I, Berning J, Putzfeld V, Janssen B, Bottlender R, Maurer K, Möller HJ, Gaebel W, Häfner H, Maier W, Klosterkötter J, Bechdolf A. [Neuropsychological Functioning as a Predictor of Treatment Response to Psychoeducational, Cognitive Behavioral Therapy in People at Clinical High Risk of First Episode Psychosis]. Psychiatr Prax. 2015 42(6):313-9.
Wölwer W, Baumann A, Bechdolf A, Buchkremer G, Häfner H, Janssen B, Klosterkötter J, Maier W, Möller HJ, Ruhrmann S, Gaebel W. The German Research Network on Schizophrenia--impact on the management of schizophrenia. Dialogues Clin Neurosci. 2006 8(1):115-21.
an der Heiden W, Häfner H. Investigating the long-term course of schizophrenia by sequence analysis. Psychiatry Res. 2015 228(3):551-9. Epub 2015 Jun 19.
an der Heiden W, Könnecke R, Wening U, Ropeter D, Maurer K, Häfner H. [Developmental conditions and subjective experiences of children with a schizophrenic parent--qualitative and quantitative studies from the Mannheim Study of Children at Risk.]. Psychiatr Prax. 2006 33(6):269-76.


Zentralinstitut für Seelische Gesundheit (ZI) - https://www.zi-mannheim.de